4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine
C46H28N2S — CID 138600123
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine
4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine (PubChem CID 138600123) has the molecular formula C46H28N2S and a molecular weight of 640.81 g/mol. Its IUPAC name is 4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine.
Molecular Properties
| Compound Name | 4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine |
|---|---|
| PubChem CID | 138600123 |
| Molecular Formula | C46H28N2S |
| Molecular Weight | 640.81 g/mol |
| Exact Mass | 640.20 |
| IUPAC Name | 4-(10-dibenzothiophen-2-yltriphenylen-1-yl)-2,6-diphenylpyrimidine |
| SMILES | c1ccc(-c2cc(-c3cccc4c5ccccc5c5cc(-c6ccc7sc8ccccc8c7c6)ccc5c34)nc(-c3ccccc3)n2)cc1 |
| InChI | InChI=1S/C46H28N2S/c1-3-12-29(13-4-1)41-28-42(48-46(47-41)30-14-5-2-6-15-30)38-20-11-19-36-33-16-7-8-17-34(33)39-26-31(22-24-37(39)45(36)38)32-23-25-44-40(27-32)35-18-9-10-21-43(35)49-44/h1-28H |
| InChIKey | LLVROFHVEQUBRG-UHFFFAOYSA-N |
| XLogP | 12.97 |
| TPSA | 25.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 640.81 |
| LogP ≤ 5 | 12.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138600123 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.